Portland, OR, Nov. 25, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global High Potency APIs Market generated $19.7 billion in 2021, and is projected to reach $41.4 billion by 2031, growing at a CAGR of 7.7% from 2022 to 2031. The report offers a detailed analysis of the top winning strategies, evolving market trends, market size and estimations, value chain, key investment pockets, drivers & opportunities, competitive landscape, and regional landscape. The report is a useful source of information for new entrants, shareholders, frontrunners, and shareholders in introducing necessary strategies for the future and taking essential steps to significantly strengthen and heighten their position in the market.
Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/31911
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Base Year | 2021 |
| Market Size in 2021 | $19.7 billion |
| Market Size in 2031 | $41.4 billion |
| CAGR | 7.7% |
| No. of Pages in Report | 310 |
| Segments Covered | Product Type, Application, Type of Synthesis, and Region. |
| Drivers | Growing demand for high potency drugs for treating cardiovascular diseases, cancer, glaucoma, and hormonal imbalances. |
| Surge in need for cost efficient generic drugs. | |
| Opportunities | Rapid technological advancements in diagnosis and treatment of chronic disorders. |
| Surge in allocation of funds by healthcare and biotech firms. | |
| Restrains | High risk of cross-contamination, need for huge capital investments, and need for high technical expertise for producing high potency drugs. |
COVID-19 Scenario:
- The outbreak of the COVID-19 had a positive impact on the growth of the global high potency APIs market, owing to rise in investment made by key industry players for developing high potency APIs for treating contagious diseases.
- However, supply chain disruptions resulted in lack of supply of raw materials during the pandemic. This moderately impacted the growth of the global market during the COVID-19 pandemic.
The report offers a detailed segmentation of the global high potency APIs market based on product type, application, type of synthesis, and region. The report provides a comprehensive analysis of every segment and their respective sub-segment with the help of graphical and tabular representation. This analysis can essentially help market players, investors, and new entrants in determining and devising strategies based on the fastest-growing segments and highest revenue generation that is mentioned in the report.
Based on product type, the innovative high-potency API segment held the major market share in 2021, holding more than two-thirds of the global high potency APIs market share, and is expected to maintain its leadership status during the forecast period. Furthermore, the same segment, is expected to cite the fastest CAGR of 8.2% during the forecast period. The report also includes other segments such as generic high-potency API.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/31911
Based on application, the oncology segment held the largest market share in 2021, accounting for more than half of the global high potency APIs market share, and is expected to maintain its leadership status during the forecast period. In addition, the same segment, is expected to cite the highest CAGR of 8.9% during the forecast period. The report also includes other segments such as hormonal imbalance, glaucoma, and others.
Based on type of synthesis, the biotech segment held the major market share in 2021, contributing around three-fifths of the global high potency APIs market share, and is expected to maintain its leadership position during the forecast period. Moreover, the same segment, on the other hand, is expected to cite the fastest CAGR of 8.2% during the forecast period.
Based on region, the market across the North American region held the major market share in 2021, holding more than two-fifths of the global high potency APIs market share and is expected to maintain its leadership status during the forecast period. However, the Asia-Pacific high potency APIs market is expected to cite the fastest CAGR of 9.5% during the forecast period. The report also analyses other regions such as Europe and LAMEA.
The key players analyzed in the global high potency APIs market report include Abbvie Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb, Eli Lilly and Company, F. Hoffmann- La Roche Ltd., Novartis AG, Pfizer Inc., Sanofi S.A., and Teva Pharmaceutical Industries Ltd.
The report analyzes these key players in the global high potency APIs market. These market players have made effective use of strategies such as joint ventures, collaborations, expansion, new product launches, partnerships, and others to maximize their foothold and prowess in the industry. The report is helpful in analyzing recent developments, product portfolio, business performance, and operating segments by prominent players in the market.
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Heart Transplant Market by Type (Ventricular Assist Devices, Total Artificial Hearts, and Others) and End User (Hospitals Cardiac Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
Compounding Pharmacies Market by Therapeutic Area (Pain Management, Hormone Replacement Therapy, Dermal Disorders, Nutritional Supplements, Others), by Route of Administration (Oral, Topical, Others), by Sterility (Non-Sterile Compounding Drugs, Sterile Compounding Drugs): Global Opportunity Analysis and Industry Forecast, 2021-2031
Dementia Drugs Market by Drug Class (MAO Inhibitors, Glutamate Inhibitors, and Cholinesterase Inhibitors), Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Other Indications), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
ENT endoscopy Market by Product Type (Rigid Endoscopes, Flexible Endoscopes, and Hearing Screening Devices), and End User (Hospitals, Ambulatory Settings, and ENT Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2030
Skin Biopsy Market by Type (Shave Biopsy, Punch Biopsy, Excisional Biopsy, and Incisional Biopsy), by indication (Skin cancer, Actinic keratosis, Dermatitis, Psoriasis, Skin infection, and Others), by End User (Hospital Use, Clinic Use, Research Center, and Other): Global Opportunity Analysis and Industry Forecast, 2021-2030
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
